Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Sales: 2012-2025

Historic Return on Sales for Ani Pharmaceuticals (ANIP) over the last 14 years, with Sep 2025 value amounting to 0.05%.

  • Ani Pharmaceuticals' Return on Sales rose 6.00% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 6.00%. This contributed to the annual value of -0.03% for FY2024, which is 7.00% down from last year.
  • Ani Pharmaceuticals' Return on Sales amounted to 0.05% in Q3 2025, which was up 457.90% from -0.01% recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Return on Sales registered a high of 0.07% during Q1 2024, and its lowest value of -0.28% during Q1 2022.
  • For the 3-year period, Ani Pharmaceuticals' Return on Sales averaged around 0.01%, with its median value being -0.01% (2024).
  • In the last 5 years, Ani Pharmaceuticals' Return on Sales declined by 19bps in 2022 and then climbed by 27bps in 2023.
  • Ani Pharmaceuticals' Return on Sales (Quarterly) stood at -0.25% in 2021, then increased by 10bps to -0.15% in 2022, then climbed by 19bps to 0.04% in 2023, then declined by 7bps to -0.03% in 2024, then climbed by 6bps to 0.05% in 2025.
  • Its Return on Sales stands at 0.05% for Q3 2025, versus -0.01% for Q2 2025 and -0.03% for Q1 2025.